IL-5 and TNF-α participate in recruitment of eosinophils to intestinal mucosa in ulcerative colitis

Digestive Diseases and Sciences

Volumn 46, Issue 9, 2001, Pages 2004-2009

  Lampinen, Maria ^a   Carlson, Marie ^a   Sangfelt, Per ^a   Taha, Yesuf ^a   Thõrn, Magnus ^a   Lõõf, Lars ^a   Raab, Yngve ^a   Venge, Per ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Cytokine; Eosinophil; Inflammatory bowel disease; Migration; Ulcerative colitis

Indexed keywords

EOSINOPHIL CHEMOTACTIC FACTOR; EOTAXIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; INTERLEUKIN 5; INTERLEUKIN 5 ANTIBODY; INTERLEUKIN 8; MAJOR BASIC PROTEIN; MESALAZINE; NEUTRALIZING ANTIBODY; RANTES; STEROID; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; CYTOKINE RELEASE; EOSINOPHIL; HUMAN; HUMAN TISSUE; INTESTINE FLUID; INTESTINE MUCOSA; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; STEROID THERAPY; TISSUE INJURY; ULCERATIVE COLITIS;

ADULT; AGED; CELL MOVEMENT; CHEMOTAXIS, LEUKOCYTE; COLITIS, ULCERATIVE; EOSINOPHILS; FEMALE; HUMANS; INTERLEUKIN-5; INTESTINAL MUCOSA; MALE; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034850310     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1010659803912     Document Type: Article

References (31)

1. Activation of eosinopils in the pathophysiology of ulcerative colitis
2. Eosinophil activation in ulcerative colitis. Studies on mucosal release and localization of eosinophil granule constituents
3. Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease
4. Activated eosinophils and interleukin-5 expression in early recurrence of Crohn's disease
5. Increased intraluminal release of eosinophil granule proteins EPO, ECP, EPX, and cytokines in ulcerative colitis and proctitis in segmental perfusion
6. Mucosal allergy: Role of mast cells and eosinophil granulocytes in the gut
7. Expression of vascular adhesion molecules in inflammatory bowel disease
8. Identification of IL-5 and RANTES as the major eosinophil chemoattractants in the asthmatic lung
9. The role of interleukin-5, interleukin-8 and RANTES in the chemotactic attraction of eosinophils to the allergic lung
10. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia
11. Human monocyte chemotactic proteins-2 and 3 (MCP-2 and MCP-3) attract human eosinophils and desensitize the chemotactic resonses towards RANTES
12. Mast cells are an important cellular source of tumour necrosis factor alfa in human intestinal tissue
13. Enhanced production of monocyte chemotactic protein-3 in inflammatory bowel disease mucosa
14. Differential in situ expression of the genes encoding the chemokines MCP-1 and RANTES in human inflammatory bowel disease
15. Corticosteroid effects on cytokines and chemokines
16. A technique for segmental rectal and colonic perfusion in humans
17. An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils
18. A 48-well micro chemotaxis assembly for rapid and accurate measurement of leukocyte migration
19. Priming of eosinophil and neutrophil migratory responses by interleukin-3 and interleukin-5
20. RANTES-and interleukin-8-induced responses in normal human eosinophils: Effects of priming with interleukin-5
21. Tumor necrosis alpha induces migration of human eosinophils
22. Cytokines induce selective granulocyte chemotactic responses
23. Priming and induction of eosinophil trafficking in guinea-pig cutaneous inflammation by tumour necrosis factor α
24. Enhanced secretion of tumour necrosis factor-α IL-6 and IL-1β by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease
25. Tumor necrosis factor alpha antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis
26. Treatment of ulcerative colitis with an engineered human anti-TNF alpha antibody CDP571
27. Eosinophil priming by cytokines: From cellular signal to in vivo modulation
28. Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice
29. Glucocorticoids: Their mechanism of action and use in allergic disease
30. Inhibition of inflammatory cell recruitment by glucocorticoides: Cytokines as primary targets